Detailed information for compound 686623

Basic information

Technical information
  • TDR Targets ID: 686623
  • Name: N'-(4-methyl-2-nitrophenyl)-N-(oxolan-2-ylmet hyl)oxamide
  • MW: 307.302 | Formula: C14H17N3O5
  • H donors: 2 H acceptors: 4 LogP: 1.96 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1ccc(c(c1)[N+](=O)[O-])NC(=O)C(=O)NCC1CCCO1
  • InChi: 1S/C14H17N3O5/c1-9-4-5-11(12(7-9)17(20)21)16-14(19)13(18)15-8-10-3-2-6-22-10/h4-5,7,10H,2-3,6,8H2,1H3,(H,15,18)(H,16,19)
  • InChiKey: TUYUALGDRLCSAV-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • N'-(4-methyl-2-nitro-phenyl)-N-(tetrahydrofuran-2-ylmethyl)oxamide
  • N'-(4-methyl-2-nitrophenyl)-N-(2-tetrahydrofuranylmethyl)oxamide
  • N'-(4-methyl-2-nitro-phenyl)-N-(tetrahydrofurfuryl)oxamide
  • N'-(4-methyl-2-nitro-phenyl)-N-(oxolan-2-ylmethyl)ethanediamide

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trichomonas vaginalis CAMK family protein kinase 0.0589 0.6791 1
Loa Loa (eye worm) cyclic AMP specific phosphodiesterase PDE4D5A 0.0159 0.1646 0.2423
Echinococcus granulosus cAMP specific 3'5' cyclic phosphodiesterase 0.0182 0.1911 0.2813
Trichomonas vaginalis CAMK family protein kinase 0.0589 0.6791 1
Echinococcus multilocularis cAMP specific 3',5' cyclic phosphodiesterase 0.0182 0.1911 0.2813
Plasmodium falciparum phosphodiesterase delta, putative 0.0022 0 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0589 0.6791 1
Echinococcus multilocularis Serine:threonine protein kinase PLK4 0.0463 0.5276 0.7769
Trypanosoma cruzi polo-like protein kinase, putative 0.0589 0.6791 1
Brugia malayi Protein kinase domain containing protein 0.0061 0.0465 0.0685
Trichomonas vaginalis CAMK family protein kinase 0.0195 0.2068 0.3045
Brugia malayi Probable 3',5'-cyclic phosphodiesterase R153.1, putative 0.0159 0.1646 0.2423
Entamoeba histolytica serine/threonine protein kinase, putative 0.0589 0.6791 0.5
Plasmodium falciparum 3',5'-cyclic nucleotide phosphodiesterase, putative 0.0022 0 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0589 0.6791 1
Echinococcus granulosus leucine rich repeat serine:threonine protein 0.0061 0.047 0.0692
Echinococcus multilocularis cAMP specific 3',5' cyclic phosphodiesterase 0.0159 0.1646 0.2423
Loa Loa (eye worm) PLK/PLK1 protein kinase 0.0589 0.6791 1
Plasmodium falciparum cGMP-specific phosphodiesterase 0.0022 0 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0589 0.6791 1
Echinococcus granulosus serine:threonine protein kinase PLK1 0.0589 0.6791 1
Trichomonas vaginalis CAMK family protein kinase 0.0195 0.2068 0.3045
Plasmodium vivax phosphodiesterase gamma, putative 0.0022 0 0.5
Giardia lamblia CAMP-specific 3,5-cyclic phosphodiesterase 4B 0.0182 0.1911 0.2813
Echinococcus multilocularis leucine rich repeat serine:threonine protein 0.0061 0.0465 0.0685
Plasmodium vivax 3',5'-cyclic nucleotide phosphodiesterase, putative 0.0022 0 0.5
Echinococcus granulosus cAMP specific 3'5' cyclic phosphodiesterase 0.0159 0.1646 0.2423
Echinococcus granulosus cAMP specific 3'5' cyclic phosphodiesterase 0.0182 0.1911 0.2813
Echinococcus multilocularis cAMP specific 3',5' cyclic phosphodiesterase 0.0182 0.1911 0.2813
Brugia malayi serine/threonine-protein kinase plk-2 0.0589 0.6791 1
Trypanosoma brucei polo-like protein kinase 0.0589 0.6791 1
Onchocerca volvulus Serine\/threonine kinase homolog 0.0589 0.6791 0.5
Toxoplasma gondii 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein 0.0182 0.1911 1
Plasmodium falciparum phosphodiesterase gamma, putative 0.0022 0 0.5
Plasmodium vivax cyclic nucleotide phosphodiesterase, putative 0.0022 0 0.5
Schistosoma mansoni serine/threonine protein kinase 0.0589 0.6791 0.6791
Leishmania major protein kinase, putative,polo-like protein kinase, putative 0.0589 0.6791 1
Plasmodium falciparum 3',5'-cyclic nucleotide phosphodiesterase, putative 0.0022 0 0.5
Schistosoma mansoni camp-specific 35-cyclic phosphodiesterase 0.0182 0.1911 0.1911
Loa Loa (eye worm) hypothetical protein 0.0182 0.1911 0.2813
Plasmodium vivax 3',5'-cyclic nucleotide phosphodiesterase, putative 0.0022 0 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0589 0.6791 1
Loa Loa (eye worm) TKL/LRRK protein kinase 0.0061 0.0465 0.0685
Trypanosoma cruzi polo-like protein kinase, putative 0.0589 0.6791 1
Giardia lamblia Kinase, PLK 0.0589 0.6791 1
Plasmodium falciparum cGMP-specific phosphodiesterase 0.0022 0 0.5
Echinococcus multilocularis serine:threonine protein kinase PLK1 0.0589 0.6791 1
Echinococcus granulosus Serine:threonine protein kinase PLK4 0.0463 0.5276 0.7769
Trichomonas vaginalis CAMK family protein kinase 0.0589 0.6791 1

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.